Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multicenter, Open-Label, Single-Arm Study of YONDELIS (Trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment

Next Previous
X
Search
Trial Profile

A Multicenter, Open-Label, Single-Arm Study of YONDELIS (Trabectedin) for Subjects With Locally Advanced or Metastatic Soft Tissue Sarcoma Who Have Relapsed or Are Refractory to Standard of Care Treatment

Status: Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 12 Oct 2017

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Trabectedin (Primary)
  • Indications Ewing's sarcoma; Osteosarcoma; Soft tissue sarcoma
  • Focus Adverse reactions; Expanded access
  • Sponsors Janssen Research & Development

    • Most Recent Events

    • 12 Sep 2017 Results of a retrospective analysis assessing the efficacy and safety of trabectedin in an elderly patient subgroup with advanced leiomyosarcoma (LMS) or liposarcoma, presented at the 42nd European Society for Medical Oncology Congress.
    • 12 Sep 2017 Results (n=1803) of retrospective analysis assessing efficacy and safety of patients treated long-term with trabectedin on the expanded access program, were presented at the 42nd European Society for Medical Oncology Congress.
    • 17 Nov 2015 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top